U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Benzalkonium_chloride

Benzalkonium chloride, also known as BZK, BKC, BAC, alkyldimethylbenzylammonium chloride and ADBAC, is a type of cationic surfactant. It is an organic salt called a quaternary ammonium compound. In 2011, a large clinical trial designed to evaluate the efficacy of hand sanitizers based on different active ingredients in preventing virus transmission amongst schoolchildren was re-designed to exclude sanitizers based on benzalkonium chloride due to safety concerns. Benzalkonium chloride has been in common use as a pharmaceutical preservative and antimicrobial since the 1940s. While early studies confirmed the corrosive and irritant properties of benzalkonium chloride, investigations into the adverse effects of, and disease states linked to, benzalkonium chloride have only surfaced during the past 30 years. Benzalkonium chloride is classed as a Category III antiseptic active ingredient by the United States Food and Drug Administration. Ingredients are categorised as Category III when "available data are insufficient to classify as safe and effective, and further testing is required”. Benzalkonium chloride is excluded from the current United States Food and Drug Administration review of the safety and effectiveness of consumer antiseptics and topical antimicrobial over-the-counter drug products, meaning it will remain a Category III ingredient. The mechanism of bactericidal/microbicidal action is thought to be due to disruption of intermolecular interactions. This can cause dissociation of cellular membrane lipid bilayers, which compromises cellular permeability controls and induces leakage of cellular contents. Other biomolecular complexes within the bacterial cell can also undergo dissociation. Enzymes, which finely control a wide range of respiratory and metabolic cellular activities, are particularly susceptible to deactivation. Critical intermolecular interactions and tertiary structures in such highly specific biochemical systems can be readily disrupted by cationic surfactants. Benzalkonium chloride is a human skin and severe eye irritant. It is a suspected respiratory toxicant, immunotoxicant, gastrointestinal toxicant and neurotoxicant.

Approval Year

PubMed

PubMed

TitleDatePubMed
Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.
1994 Jun
[Contact sensitization to pharmaceutic aids in dermatologic cosmetic and external use preparations].
2004 May
Contact sensitivity to preservatives in Turkey.
2005 Jun
Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells.
2005 Mar
CXCL8 secretion by dendritic cells predicts contact allergens from irritants.
2006 Feb
Human skin in organ culture and human skin cells (keratinocytes and fibroblasts) in monolayer culture for assessment of chemically induced skin damage.
2007 Aug
Suitability of macrophage inflammatory protein-1beta production by THP-1 cells in differentiating skin sensitizers from irritant chemicals.
2008 Apr
Occludin gene expression as an early in vitro sign for mild eye irritation assessment.
2010 Feb
Upregulation of genes orchestrating keratinocyte differentiation, including the novel marker gene ID2, by contact sensitizers in human bulge-derived keratinocytes.
2010 Jan-Feb
Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes.
2010 Nov 10
An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8.
2011 Dec
Development of an in vitro alternative assay method for vaginal irritation.
2011 Jan 11
Cross talk between keratinocytes and dendritic cells: impact on the prediction of sensitization.
2011 Oct
Localization and expression of zonula occludins-1 in the rabbit corneal epithelium following exposure to benzalkonium chloride.
2012
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.
2013 Dec
Development of an in vitro dendritic cell-based test for skin sensitizer identification.
2013 Mar 18
Characterizing the immunological effects of oral healthcare ingredients using an in vitro reconstructed human epithelial model.
2014 Dec
Identification of cornifelin and early growth response-1 gene as novel biomarkers for in vitro eye irritation using a 3D reconstructed human cornea model MCTT HCE™.
2015 Sep
Patents

Sample Use Guides

Unknown
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: Cell exposure to 0.1% and 0.05% BAC induced cell lysis immediately after treatment. All cells (100%) treated with 0.01% BAC died in a delayed manner within 24 hours, with most of the characteristics of apoptosis (chromatin condensation and DNA fragmentation, reduction in cell volume, expression of the apoptotic marker Apo 2.7, and apoptotic changes in DNA content).
A continuous human conjunctival cell line (Wong-Kilbourne derivative of Chang conjunctiva) was exposed to benzalkonium chloride (BAC) solutions at various concentrations (0.1%-0.0001%) during a period of 10 minutes.
Name Type Language
ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE (C12-C14)
Common Name English
BTC 2125M Component N-ALKYL DIMETHYL BENZYL AMMONIUM CHLORIDE (C12-C14)
Brand Name English
ALKYL(C12-14)DIMETHYLBENZYLAMMONIUM CHLORIDE
Common Name English
Code System Code Type Description
CAS
68424-85-1
Created by admin on Sat Dec 16 19:52:11 GMT 2023 , Edited by admin on Sat Dec 16 19:52:11 GMT 2023
ALTERNATIVE
FDA UNII
5R9MGR4CR5
Created by admin on Sat Dec 16 19:52:11 GMT 2023 , Edited by admin on Sat Dec 16 19:52:11 GMT 2023
PRIMARY
CAS
8001-54-5
Created by admin on Sat Dec 16 19:52:11 GMT 2023 , Edited by admin on Sat Dec 16 19:52:11 GMT 2023
PRIMARY
All of the following components must be present:
Definition References